ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine

This study has been completed.

Sponsor:

Collaborator:

Information provided by (Responsible Party):

Alkermes

ClinicalTrials.gov Identifier:

NCT01366001

First received: June 2, 2011

Last updated: March 8, 2012

Last verified: March 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2012
Primary Completion Date:	February 2012 (Final data collection date for primary outcome measure)